The largest database of trusted experimental protocols

Pgl3 basic luciferase vector

Manufactured by GenePharma
Sourced in China

The PGL3-Basic luciferase vector is a plasmid designed for use in reporter gene assays. It contains the firefly luciferase gene as the reporter, which can be used to measure gene expression levels in cells. The vector provides a basic backbone for cloning and expressing target genes of interest.

Automatically generated - may contain errors

4 protocols using pgl3 basic luciferase vector

1

Validating miR-26a binding to SLC7A11 mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The binding sites between miR-26a and SLC7A11 mRNA were predicted by the miRDB and targetScan online website. LX2 cells were seeded into the 24‑well plates and grown with 5% CO2 at 37°C. When the cells’ confluency reached 70–80%, the transfection was conducted. Wild-type SLC7A11 (SLC7A11-WT) and mutant SLC7A11 (SLC7A11-MUT) were sub-cloned into pGL3-Basic luciferase vector (2 μg/mL, GenePharma) and then transfected into LX2 cells with miR-26a-mimic or NC-mimic using Lipofectamine™ 3000 (Cat#: L3000001, Invitrogen). Forty-eight hours later, luciferase activity was measured by a Dual Luciferase Reporter Gene Assay Kit (Cat#: RG027, Beyotime) based on the instruction for use.
+ Open protocol
+ Expand
2

Luciferase Reporter Assay for circZFR and ZEB2

Check if the same lab product or an alternative is used in the 5 most similar protocols
For luciferase reporter assay, circZFR-WT, circZFR-mutant, ZEB2-WT and ZEB2-mutant were constructed into pGL3-Basic luciferase vector (GenePharma, Shanghai, China) to construct reporter plasmids. Afterwards, cells were co-transfected with indicated reporter plasmids and microRNA using Lipofectamine 2000 (Life Technologies). Subsequently, the relative luciferase activity was detected by the dual-luciferase reporter assay system (Promega, Madison, WI, U.S.A.) at 48 h post-transfection. Firefly luciferase activity was normalized to renilla luciferase activity.
+ Open protocol
+ Expand
3

Luciferase Reporter Assay for miR-143-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
MyD88 wild-type and its corresponding mutant were built into a pGL3-basic luciferase vector (2 μg/mL; Shanghai GenePharma, Shanghai, China) to generate the luciferase reporter plasmids. Cells at the third passage were inoculated onto 24 well plates at a density of 4 × 104 cells/well and cultured at 37°C. When the cells reached ~ 70% confluence, they were co-transfected with luciferase reporter plasmids, miR-143-3p mimic, or NC mimic using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific) according to the manufacturer’s instructions. Luciferase activity was examined using a dual-luciferase reporter assay kit (cat. no. E1910; Promega Corporation, Madison, WI, USA) following transfection for 24 h [29 (link)].
+ Open protocol
+ Expand
4

Luciferase Reporter Assay for miR-143-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
MyD88 wild-type and its corresponding mutant were built into pGL3-basic luciferase vector (2 µg/mL; Shanghai GenePharma Co., Ltd., China) to generate the luciferase reporter plasmids. Cells at the third passage were inoculated into 24-well plates at a density of 4×10 4 cells per well and cultured at 37℃. When reached about 70% con uence, cells were co-transfected with luciferase reporter plasmids, miR-143-3p mimic or NC mimic by using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scienti c, USA) according to the operating instructions. Luciferase activity was examined with a dual-luciferase reporter assay kit (cat. no. E1910; Promega Corporation, Madison, USA) following transfection for 24 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!